跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PENTASA mesalazine 0.5 g prolonged release tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
PENTASA mesalazine 0.5 g prolonged release tablet blister pack
Approved
STANDARD
PENTASA mesalazine 0.5 g prolonged release tablet blister pack
Ferring Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
32a952a0036ef530
Company
Ferring Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
32a952a0036ef530
Product Name
PENTASA mesalazine 0.5 g prolonged release tablet blister pack
Artg Id
99139
Artg Name
PENTASA mesalazine 0.5 g prolonged release tablet blister pack
Sponsor
Ferring Pharmaceuticals Pty Ltd
Company Detail Path
/organization/ferring-pharmaceuticals-inc
Artg Date
2007-01-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/f5fa469dff47617266efb2ffd4e4aba7.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1d0fc2cfde01393eb6ee9c990fdae934.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
32a952a0036ef530
Type
Standard
Back to TGA Approvals